Skip to site menu Skip to page content
Curia Global
Go back

Sterile Filtration of Budesonide as a Preferred Sterilisation Strategy

Sterile budesonide manufacturing requires a sterilisation strategy that protects both chemical integrity and critical quality attributes. Because the molecule is highly sensitive to thermal, oxidative, and radiolytic stress, selecting the appropriate sterilisation approach is essential for maintaining product quality throughout manufacturing. This whitepaper explores why sterile filtration is widely recognised as a preferred method for sterile budesonide API production and examines the key process considerations that support successful implementation. Download the whitepaper to learn about:
  • The limitations of traditional sterilisation methods for budesonide
  • Comparative considerations for moist heat, dry heat, irradiation, HTST, and supercritical CO₂ approaches
  • Why sterile filtration can help preserve critical quality attributes
  • The importance of validated aseptic processing and sterilising-grade filtration
  • Downstream manufacturing considerations from crystallisation through final packaging
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content